Glucocorticoid-induced changes in the geometry of osteoclast resorption cavities affect trabecular bone stiffness

Calcified Tissue International

Volumn 92, Issue 3, 2013, Pages 240-250

  Vanderoost, Jef ^a   Søe, Kent ^b   Merrild, Ditte Marie Horslev ^b   Delaissé, Jean Marie ^b   Van Lenthe, G Harry ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biomechanics; Bone architecture structure; Osteoclasts; Osteoporosis: secondary drug induced; Steroid hormones: glucocorticoids

Indexed keywords

GLUCOCORTICOID;

ARTICLE; BIOMECHANICS; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; FEMALE; FINITE ELEMENT ANALYSIS; GEOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMBAR SPINE; MUSCULOSKELETAL STIFFNESS; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; TRABECULAR BONE;

EID: 84873729112     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9674-6     Document Type: Article

References (43)

1. Chavassieux P, Seeman E, Delmas PD (2007) Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 28:151-164
2. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328
3. van Brussel MS, Bultink IE, Lems WF (2009) Prevention of glucocorticoid-induced osteoporosis. Expert Opin Pharmacother 10:997-1005
4. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
5. Garnero P (2009) Bone markers in osteoporosis. Curr Osteoporos Rep 7:84-90
6. Lewiecki EM (2010) Bone densitometry and vertebral fracture assessment. Curr Osteoporos Rep 8:123-130
7. Helfrich MH, Ralston SH (eds) (2003) Bone research protocols. Humana Press, Totowa
8. van Lenthe GH, Mueller TL, Wirth AJ, Muller R (2008) Quantification of bone structural parameters and mechanical competence at the distal radius. J Orthop Trauma 22:S66-S72
9. Mueller TL, van Lenthe GH, Stauber M, Gratzke C, Eckstein F, Muller R (2009) Regional, age and gender differences in architectural measures of bone quality and their correlation to bone mechanical competence in the human radius of an elderly population. Bone 45:882-891
10. Yeni YN, Fyhrie DP (2001) Finite element calculated uniaxial apparent stiffness is a consistent predictor of uniaxial apparent strength in human vertebral cancellous bone tested with different boundary conditions. J Biomech 34:1649-1654
11. van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224-3229
12. van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79:129-137
13. Alesci S, De Martino MU, Ilias I, Gold PW, Chrousos GP (2005) Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. NeuroImmunoModulation 12:1-19
14. Aaron JE, Francis RM, Peacock M, Makins NB (1989) Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop Relat Res 243:294-305
15. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK (2001) Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 142:5371-5378
16. Soe K, Delaisse JM (2010) Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle. J Bone Miner Res 25:2184-2192
17. Vanderoost J, Jaecques SV, Van der PG, Boonen S, D'hooge J, Lauriks W, van Lenthe GH (2011) Fast and accurate specimen-specific simulation of trabecular bone elastic modulus using novel beam-shell finite element models. J Biomech 44:1566-1572
18. Vanderoost J (2012) Relating bone structure to competence: role of local trabecular properties. PhD diss., Katholieke Universiteit Leuven
19. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaisse JM (2005) Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation. Cancer Res 65:9943-9952
20. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM (2002) Osteoblastic 11 beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979-986
21. Dequeker J (1994) Assessment of quality of bone in osteoporosis-BIOMED I: fundamental study of relevant bone. Clin Rheumatol 13(suppl 1):7-12
22. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174
23. Aerssens J, Boonen S, Joly J, Dequeker J (1997) Variations in trabecular bone composition with anatomical site and age: potential implications for bone quality assessment. J Endocrinol 155:411-421
24. Vedi S, Compston JE, Webb A, Tighe JR (1982) Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res 4:231-236
25. Croucher PI, Garrahan NJ, Mellish RW, Compston JE (1991) Age-related changes in resorption cavity characteristics in human trabecular bone. Osteoporos Int 1:257-261
26. Croucher PI, Garrahan NJ, Compston JE (1993) Assessment of resorption cavity characteristics in trabecular bone: changes in primary and secondary osteoporosis. Bone 14:449-454
27. Chavassieux PM, Arlot ME, Roux JP, Portero N, Daifotis A, Yates AJ, Hamdy NA, Malice MP, Freedholm D, Meunier PJ (2000) Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies. J Bone Miner Res 15:754-762
28. Muller R, van Lenthe GH (2006) Trabecular bone failure at the microstructural level. Curr Osteoporos Rep 4:80-86
29. Gentzsch C, Junge M, Pueschel K, Delling G, Kaiser E (2005) A scanning electron microscopy-based approach to quantify resorption lacunae applied to the trabecular bone of the femoral head. J Bone Miner Metab 23:205-211
30. Gentzsch C, Delling G, Kaiser E (2003) Microstructural classification of resorption lacunae and perforations in human proximal femora. Calcif Tissue Int 72:698-709
31. Jones SJ, Boyde A (1994) Questions of quality and quantity - a morphological view of bone biology. Acta Anatomica Nipponica 69:229-243
32. Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR (1986) Scanning electron-microscopy in bone pathology - review of methods, potential and applications. Scanning Electron Microsc 1986:1537-1554
33. Compston JE, Croucher PI (1991) Histomorphometric assessment of trabecular bone remodelling in osteoporosis. Bone Miner 14:91-102
34. Seeman E, Delmas PD (2006) Bone quality - the material and structural basis of bone strength and fragility. N Engl J Med 354:2250-2261
35. Heaney RP (2003) Is the paradigm shifting? Bone 33:457-465
36. Hernandez CJ, Gupta A, Keaveny TM (2006) A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res 21:1248-1255
37. Eriksen EF, Mosekilde L, Melsen F (1985) Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone 6:141-146
38. Dalle CL, Bertoldo F, Valenti MT, Zenari S, Zanatta M, Sella S, Giannini S, Cascio VL (2005) Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron 36:645-652
39. Seeman E, Delmas PD (2006) Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 354:2250-2261
40. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
41. Dovio A, Perazzolo L, Saba L, Termine A, Capobianco M, Bertolotto A, Angeli A (2006) High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption. Eur J Endocrinol 154:745-751
42. Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milano E, Bertolotto A, Angeli A (2004) Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 89:4923-4928
43. De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208-214